Newstral
Article
bizjournals.com on 2018-07-23 19:50
Local biopharma Ascentage Pharma raises $150M for cancer drug pipeline
Related news
- PureTech’s Vor Biopharma raises $42M for blood cancer drugsbizjournals.com
- Biopharma startup raises $118M as it pursues innovative cancer drugsbizjournals.com
- Local Biopharma Jobs Pipeline Opensnewhavenindependent.org
- Gaithersburg biopharma raises another $11Mbizjournals.com
- Formlabs raises $150MTechCrunch
- KHormone (GH) Agonist – Pipeline Market porter’s five force analysis which has been a game-changer : Teva Pharmaceutical Industries, Ascendis Pharma, JCR Pharmaceuticals, Merck Serono, Savient Pharmaceuticals, HanAll Biopharmaksusentinel.com
- Gaithersburg biopharma company Sirnaomics raises $25Mbizjournals.com
- Biopharma startup Triumvira Immunologics raises $55Mbizjournals.com
- Vor Biopharma raises $177M in upsized IPObizjournals.com
- Main Line biopharma firm raises $25 millionbizjournals.com
- Techstars accelerator raises $150M fundbizjournals.com
- Array BioPharma reports successful cancer drug trialDenver Post
- RTP-based pharma raises $25M, preps cancer drug for clinical trialsbizjournals.com
- Biotech consortium led by PDC*line Pharma raises €8.1M for cancer vaccinetech.eu
- Alexion Pharma to pay $8.4 billion for Synageva BioPharmadothaneagle.com
- Alexion Pharma to pay $8.4B for Synageva BioPharmaseattletimes.com
- FBerlin travel start-up raises $150mft.com
- FDigital health start-up Doctolib raises €150mft.com